top of page



FDA’s AI Breakthrough: Why the Mushrooms Inc. subsidiary MYCOLabX Is Positioned for a Fast Regulatory Win
Our mycelium-based smart bandage technology represents a groundbreaking fusion of nature and science—leveraging FDA-regulated pathways to deliver active nutrients while detecting infection through visible color changes. With the FDA’s new AI-assisted review process potentially accelerating approvals, we are entering a transformative era for biotech innovation. Our approach aims to meet urgent healthcare needs in both civilian and military settings with precision and safety at

Kimberly ZAWI Carlson
6 days ago2 min read
25 views
0 comments
bottom of page